W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Management Changes
Change to the Management Board at WORLD OF MEDICINE/ New CFO assumes Management Board position effective May 1, 2005

---------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------


The Supervisory Board of medical device manufacturer WORLD OF MEDICINE today appointed Andreas Schröteler to be its new Chief Financial Officer, effective May 1, 2005. He comes to WORLD OF MEDICINE from BDO, the leading international accounting firm, where he served 13 years, for many years in an executive capacity as a Senior Manager. After an extended professional engagement in the USA, the 38 year-old is now assuming responsibility for the Departments of Accounting, Controlling, Investor Relations, IT and Materials Management.

Schröteler holds his graduate degree in business (Dipl. Kaufmann), and is a certified accountant and tax advisor. Beside his international business experience, he has expertise in the areas of financial organization and controlling, as well as a deep knowledge of US-GAAP and IFRS international accounting standards.

The preceding CFO, Michael Ott, has at his own wish decided against extending his contract, which expires this year; instead he will be pursuing a separate business engagement. The Supervisory Board today accepted his resignation from his post on the Management Board at the end of April 2005. Mr. Ott will resign from the Company effective May 31, 2005. He will remain available to WORLD OF MEDICINE in an advisory capacity for the following nine months. The Supervisory Board and Management Board wish to thank Mr. Ott for his strong commitment and his consistently effective service. They strongly regret his departure and offer him their best wishes in his future personal and professional endeavors.

The Management Board

end of announcement                                euro adhoc 15.04.2005 10:30:15

Further inquiry note: Stefanie Gehrke Tel.: +49 (0)30 39981 566 E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Berliner Wertpapierbörse / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade
              Bremer Wertpapierbörse (BWB) / free trade

Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: